Related Experiment Videos
Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether
1Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
Pharmaceutical Patent Analyst
|August 9, 2021
Abstract
No abstract available in PubMed .